 Adaptive Biotechnologies Corp NASDAQ: ADPT shares are trading higher by 12.58 to 7.25 after the company launched T-Detect Lyme, to help diagnose early lyme disease. Adaptive Biotechnologies says, in a clinical validation study among patients with early Lyme disease, the T-cell test was. 